We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Improved Silicone Breast Implants

By HospiMedica staff writers
Posted on 02 Nov 2005
A new silicone breast implant provides breast augmentation and reconstruction that result in more-natural looking breasts with a low complication rate.

The new devices are more cohesive than those currently being considered, with a gummy consistency that allows them to hold their shape better than saline implants. More...
According to a clinical study in Plastic and Reconstructive Surgery, the gummy consistency decreases the likelihood of rippling and provides greater safety because the more-solid silicone may not escape from the shell if it were to rupture. The silicone material and its textured shell also give the implant a very natural and proportionate breast shape. Another benefit found was the availability of a wide variety of shapes and sizes to more closely match breast shapes and chest dimensions.

"It is an extreme understatement to say our patients are happy with the more cohesive gel implants,” said Mitchell Brown, M.D., a member of the American Society of Plastic Surgeons (ASPS, Arlington Heights, IL, USA) and the study's author. "These implants simply look and feel much more natural than saline implants. My patients are thrilled with their results.”

The complication rate of the new implants is very low. In the study, only 3.4% of the 118 breast-augmentation patients experienced complications, which included hematoma, capsular contracture, and asymmetry. Around 19% of the 32 breast reconstruction patients experienced complications, but most were minor with only one patient requiring re-operation.

Thirteen years after restricting access to silicone implants, the U.S. Food and Drug Administration (FDA) is considering the reintroduction of silicon breast implants in the United States. In the second half of 2005, after manufacturers presented data at a hearing, the FDA issued "approval with conditions” for the sale of silicone implants, stipulating a number of conditions that manufacturers must satisfy. This new type of silicone implants has not yet received an FDA panel hearing.




Related Links:
American Society of Plastic Surgeons

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.